Partner
Frequently recommended lawyer for pharmaceutical and medical product law
Oliver is head of the practice group Environmental, Planning & Regulatory. He advises on regulatory healthcare law and his clients include major service providers and investors in the healthcare sector - hospitals, operators of medical care centres, laboratory companies, private equity houses, nursing home operators - but also statutory health insurance companies.
His practice focuses on the licensing and financing of new facilities as well as large-volume transactions, cooperations, outsourcing and PPP projects. Oliver advises his clients in particular on hospital law, the law governing authorised physicians, the law governing medical professions and the law governing statutory health insurance. He also advises on cooperations and innovative business models in the fields of e-health and telemedicine.
Eine erneute MVZ-Reform wäre der völlig falsche Weg, in: RECHT KOMMENTIERT, Ausgabe 1, 2023
Gesundheitspolitik: Weiter so, Chance oder Risiko?, in: Health&Care Management, 02/2022, together with Karolina Lange
Beck'sches Formularbuch Medizin- und Gesundheitsrecht, et al. 2017
Kostendruck, knappe Kassen und die Konsolidierung des Marktes - Rosige Zeiten für Privatinvestoren im Gesundheitswesen? in: NZS 2011, 525-531
Frequently recommended lawyer for pharmaceutical and medical product law
Frequently recommended lawyer for healthcare - Hospitals, MVZs and pharmacies
Leading individual: Public Law
Leading individual: Regulatory Practice
Ranked lawyer for Healthcare
Recommended lawyer for the public sector
Frequently recommended: Hospitals, Medical Care Centers (MVZ) and Pharmacies
Leading individual: Regulatory Practice
Ranked with Chambers and Partners for Healthcare (Germany)
Key lawyer for Healthcare
"outstanding professionally and personally", competitor
Excellent lawyer: Healthcare, pharmaceuticals & biotech
Leading individual: Regulation
Lawyer of the Year for Regulation
Recommended lawyer: Healthcare
Leading individual - Healthcare - Germany: Oliver Klöck is "calm and very experienced," according to one appreciative client. He advises on regulatory aspects of transactions for healthcare providers and private equity funds.
Frequently recommended: Hospitals, Medical Care Centers (MVZ) and Pharmacies
NORD Holding, a leading private equity house, on the acquisition of the majority interest in Zentrum Gesundheit Group, a leading German group of ophthalmic surgery and diagnostic centres, from Waterland Private Equity. NORD Holding, together with the management and medical team, acquired a stake as a new partner and majority shareholder. In this deal the Taylor Wessing team again demonstrated its interdisciplinary expertise in the areas of healthcare M&A, regulatory and acquisition financing.
Press releaseby multiple authors
Taylor Wessing advises Balderton Capital on €50 million Series B financing round in Avi Medical
by multiple authors
Chambers Europe 2022 recommends 28 Taylor Wessing lawyers from 21 Practice Areas whilst Data Protection is listed for the first time
by multiple authors
by Alison Dennis and Alice Matthews
by Dr. Markus Böhme, LL.M. (Nottingham) and Rebekka Ackermann
by Colin McCall and Charlie Adams
by Paul Orij and Andrei Babiy
by Toon Rummens
by multiple authors
by Dr. Anja Lunze, LL.M. and Dr. Aurel-Damian Roscher, LL.M.
by multiple authors